Tricida, Inc. announced the hiring of Elizabeth Faust, Ph.D., as Senior Vice President of Medical Affairs. Dr. Faust, who initially joined Tricida as a consultant in September 2019, will lead the strategic development and implementation of Tricida’s medical education, publications and disease awareness activities as the company prepares for the potential launch of veverimer in 2020. Dr. Faust has over 20 years of medical affairs experience in the bio-pharmaceutical industry. She has played a key contributing role in nine drug launches across several therapeutic areas. Previously, Dr. Faust served as Vice President of Medical Affairs at Pharmacyclics where she built and led the medical affairs function supporting the execution of four indication launches for Imbruvica over 14 months. Most recently, Dr. Faust served as Vice President of Medical Affairs at Kite Pharma where she built and led the medical affairs function supporting the launch of Yescarta. Dr. Faust has also served in senior roles in medical affairs at Celgene, Gloucester Pharmaceuticals and Amgen.